Valuation : Novartis AG

Market Cap 300B 258B 242B 221B 417B 28,620B 419B 2,861B 1,109B 14,438B 1,127B 1,102B 47,822B P/E 2026 *
22.4x
P/E 2027 * 19.1x
Enterprise Value 333B 286B 268B 245B 462B 31,737B 464B 3,172B 1,229B 16,011B 1,249B 1,222B 53,030B EV / Sales 2026 *
5.77x
EV / Sales 2027 * 5.35x
Free-Float
91.66%
Yield 2026 *
2.77%
Yield 2027 * 2.89%
1 day-1.39%
1 week-0.59%
Current month-0.79%
1 month-2.27%
3 months+5.03%
6 months-3.75%
Current year+14.60%
1 week 124.7
Extreme 124.7
128.68
1 month 121.02
Extreme 121.02
131.5
Current year 107.68
Extreme 107.68
131.5
1 year 96.03
Extreme 96.03
131.5
3 years 81.1
Extreme 81.1
131.5
5 years 72.84
Extreme 72.84
131.5
10 years 65.09
Extreme 65.09
131.5
Manager TitleAgeSince
Chief Executive Officer 50 31/01/2018
Director of Finance/CFO - 15/03/2026
Compliance Officer 58 13/04/2025
Director TitleAgeSince
Director/Board Member 67 31/12/2014
Director/Board Member 69 31/12/2015
Director/Board Member 61 31/12/2015
Date Insider Type Main position Quantity % Market Cap.
17/02/26 Sell 30,743 0.0015%
10/02/26 Sell 7,500 0.0004%
09/02/26 Sell 67,000 0.0032%
Change 5-day change 1-year change 3-year change Capi.($)
-1.44%-0.59%+23.16%+38.85% 300B
-3.59%-7.10%+61.60%+114.83% 1,060B
-1.15%-1.25%+52.98%+62.41% 651B
-1.09%-1.15%+26.18%+79.22% 465B
-1.14%-1.69%+39.19%+41.04% 365B
-0.66%+1.00%+2.51%+12.64% 258B
-0.43%-0.46%+52.06%+71.75% 238B
-3.21%-0.29%-17.21%-54.32% 210B
-0.46%+0.33%+29.05%+92.67% 184B
-0.95%+0.21%+13.56%-22.21% 161B
Average -1.06%-0.11%+28.31%+43.69% 389.17B
Weighted average by Cap. -0.74%-1.87%+38.58%+63.76%

Financials

2026 *2027 *
Net sales 57.65B 49.48B 46.44B 42.42B 80.05B 5,498B 80.44B 550B 213B 2,774B 216B 212B 9,188B 61.31B 52.62B 49.39B 45.11B 85.13B 5,848B 85.54B 584B 227B 2,950B 230B 225B 9,771B
Net income 13.95B 11.97B 11.24B 10.26B 19.37B 1,331B 19.47B 133B 51.54B 671B 52.38B 51.24B 2,223B 15.5B 13.31B 12.49B 11.41B 21.53B 1,479B 21.63B 148B 57.27B 746B 58.2B 56.94B 2,471B
Net Debt 32.68B 28.05B 26.33B 24.05B 45.38B 3,117B 45.6B 312B 121B 1,572B 123B 120B 5,208B 27.82B 23.88B 22.41B 20.47B 38.63B 2,653B 38.81B 265B 103B 1,339B 104B 102B 4,433B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
27/08/26 CHF 125.40 -1.40% 650,628
26/08/26 CHF 127.18 -0.90% 1,481,053
25/08/26 CHF 128.34 +1.25% 1,729,051
24/08/26 CHF 126.76 -0.52% 1,658,623
21/08/26 CHF 127.42 +0.85% 2,706,020
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
157.87USD
Average target price
154.32USD
Spread / Average Target
-2.25%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock